Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
2QjFSeGgK1sW1RwH